BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38606546)

  • 1. Hospital-associated venous thromboembolism prophylaxis use by risk assessment at a large integrated health care network in Northern California.
    Xu J; Neeman E; Thai KK; Mishra P; Schlessinger D; Clancy H; Myers L; Roubinian N; Liu V; Liu R
    J Hosp Med; 2024 Apr; ():. PubMed ID: 38606546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a novel and scalable clinical decision support intervention to improve venous thromboembolism prophylaxis: a quasi-experimental study.
    Umscheid CA; Hanish A; Chittams J; Weiner MG; Hecht TE
    BMC Med Inform Decis Mak; 2012 Aug; 12():92. PubMed ID: 22938083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends and Risk Factors for Venous Thromboembolism Among Hospitalized Medical Patients.
    Neeman E; Liu V; Mishra P; Thai KK; Xu J; Clancy HA; Schlessinger D; Liu R
    JAMA Netw Open; 2022 Nov; 5(11):e2240373. PubMed ID: 36409498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism : a cohort study.
    Flanders SA; Greene MT; Grant P; Kaatz S; Paje D; Lee B; Barron J; Chopra V; Share D; Bernstein SJ
    JAMA Intern Med; 2014 Oct; 174(10):1577-84. PubMed ID: 25133488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Three-year Retrospective Study Looking at Preventing Hospital Acquired Thrombosis.
    Kammath V; Gupta A; Bald A; Hope G; Kansal N; Al Samaraee A; Bhattacharya V
    Cardiovasc Hematol Agents Med Chem; 2024 Jan; ():. PubMed ID: 38288832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automating Venous Thromboembolism Risk Calculation Using Electronic Health Record Data upon Hospital Admission: The Automated Padua Prediction Score.
    Elias P; Khanna R; Dudley A; Davies J; Jacolbia R; McArthur K; Auerbach AD
    J Hosp Med; 2017 Apr; 12(4):231-237. PubMed ID: 28411291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ability of Caprini and Padua risk-assessment models to predict venous thromboembolism in a nationwide Veterans Affairs study.
    Hayssen H; Sahoo S; Nguyen P; Mayorga-Carlin M; Siddiqui T; Englum B; Slejko JF; Mullins CD; Yesha Y; Sorkin JD; Lal BK
    J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101693. PubMed ID: 37838307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved compliance with venous thromboembolism pharmacologic prophylaxis for patients with gynecologic malignancies hospitalized for nonsurgical indications did not reduce venous thromboembolism incidence.
    Prescott LS; Kidin LM; Downs RL; Cleveland DJ; Wilson GL; Munsell MF; DeJesus AY; Cain KE; Ramirez PT; Kroll MH; Levenback CF; Schmeler KM
    Int J Gynecol Cancer; 2015 Jan; 25(1):152-9. PubMed ID: 25365592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decision support systems in clinical practice: The case of venous thromboembolism prevention.
    Nazarenko GI; Kleymenova EB; Payushik SA; Otdelenov VA; Sychev DA; Yashina LP
    Int J Risk Saf Med; 2015; 27 Suppl 1():S104-5. PubMed ID: 26639683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ability of Caprini and Padua Risk-Assessment Models to Predict Venous Thromboembolism in a Nationwide Study.
    Hayssen H; Sahoo S; Nguyen P; Mayorga-Carlin M; Siddiqui T; Englum B; Slejko JF; Mullins CD; Yesha Y; Sorkin JD; Lal BK
    medRxiv; 2023 Mar; ():. PubMed ID: 36993603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.
    Kahn SR; Morrison DR; Diendéré G; Piché A; Filion KB; Klil-Drori AJ; Douketis JD; Emed J; Roussin A; Tagalakis V; Morris M; Geerts W
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008201. PubMed ID: 29687454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and implementation of venous thromboembolism stewardship across a hospital network.
    Chong J; Curtain C; Gad F; Passam F; Soo G; Levy R; Dunkley S; Wong Doo N; Cunich M; Burke R; Chen V
    Int J Med Inform; 2021 Nov; 155():104575. PubMed ID: 34560489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism (VTE) risk stratification in general medical patients at an academic medical center.
    Fritz MK; Kincaid SE; Sargent CG; Green AH; Davis GA
    J Thromb Thrombolysis; 2021 Jan; 51(1):67-73. PubMed ID: 32447745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of venous thromboembolism prophylaxis in American hospitalized pregnant women undergoing cesarean section.
    Pon TK; Wessel N; Cagonot V; Delmonte R; Roach D; Finta L
    Int J Clin Pharm; 2019 Feb; 41(1):264-271. PubMed ID: 30661217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing the incidence of hospital-associated venous thromboembolism within a network of academic hospitals: Findings from five University of California medical centers.
    Jenkins IH; White RH; Amin AN; Afsarmanesh N; Auerbach AD; Khanna R; Maynard GA
    J Hosp Med; 2016 Dec; 11 Suppl 2():S22-S28. PubMed ID: 27925421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).
    Depietri L; Marietta M; Scarlini S; Marcacci M; Corradini E; Pietrangelo A; Ventura P
    Intern Emerg Med; 2018 Jun; 13(4):527-534. PubMed ID: 29502330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Electronic Alert System Is Associated With a Significant Increase in Pharmacologic Venous Thromboembolism Prophylaxis Rates Among Hospitalized Inflammatory Bowel Disease Patients.
    Mathers B; Williams E; Bedi G; Messaris E; Tinsley A
    J Healthc Qual; 2017; 39(5):307-314. PubMed ID: 27153049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and effectiveness of a risk-stratified venous thromboembolism prophylaxis algorithm in young people with cystic fibrosis.
    Holsteen P; Meier M; Brennan L; VanHorn T; Kuldanek SA; Wang M; Martiniano SL
    Thromb Res; 2021 Oct; 206():36-41. PubMed ID: 34399123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing prevention of hospital-acquired venous thromboembolism (VTE): prospective validation of a VTE risk assessment model.
    Maynard GA; Morris TA; Jenkins IH; Stone S; Lee J; Renvall M; Fink E; Schoenhaus R
    J Hosp Med; 2010 Jan; 5(1):10-8. PubMed ID: 19753640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality gap in venous thromboembolism prophylaxis practices in inpatients: Assessment of prophylaxis practices in a University Hospital.
    Güven AT; Altintop SE; Özdede M; Uyaroğlu OA; Tanriöver MD
    Int J Qual Health Care; 2021 Jul; 33(3):. PubMed ID: 34270730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.